口咽吞咽困难:面向神经老年医学整合视角的叙述性综述
口咽吞咽困难在神经老年人群中常见,增加营养不良、肺炎和死亡风险,表现为多病因综合征。本文倡导神经老年医学视角,整合神经病学洞见与老年医学原则,强调疾病特异性表现及神经治疗潜力,并汇总跨疾病管理策略与研究方向。
要点
- 口咽吞咽困难增加神经老年患者营养不良、肺炎和死亡风险。
- 神经老年医学视角强调疾病特异性表现及神经治疗潜力。
- 跨疾病策略包括口腔卫生、营养支持、饮食调整和神经刺激。
核心结论
- 口咽吞咽困难是神经老年人群中的多病因综合征,需从神经老年医学整合视角管理。
- 该视角强调疾病特异性神经表现与老年医学原则结合,以改善吞咽困难管理。
研究设计与样本
- 叙述性综述,未报告系统检索范围或样本量。
主要发现
- 口咽吞咽困难在神经老年人群常见,增加营养不良、肺炎和死亡风险。
- 乙酰胆碱酯酶抑制剂在肌无力及多巴胺能药物在帕金森病中显示对该综合征的益处。
- 年龄相关因素如老年性吞咽(咽部感觉减退、肌少症、神经可塑性下降)参与病理生理。
关键数值与推荐
- 跨疾病治疗策略包括口腔卫生、营养支持、饮食调整、个体化改善吞咽生理的干预及研究中神经刺激技术。
- 研究目标包括完善针对干预的评估方案、识别结局预测因素及评估神经刺激或药物的潜力。
临床怎么用
- 对神经老年患者应关注口咽吞咽困难,综合管理营养不良、肺炎和死亡风险。
- 可考虑疾病特异性神经治疗(如肌无力用乙酰胆碱酯酶抑制剂、帕金森病用多巴胺能药物)对吞咽困难的潜在益处。
- 实施跨疾病策略:口腔卫生、营养支持、饮食调整、个体化吞咽生理干预及研究中的神经刺激技术。
局限性
- 本文为叙述性综述,未报告系统检索策略、证据等级或样本量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Oropharyngeal dysphagia, prevalent in neurogeriatric populations, increases the risks of malnutrition, pneumonia, and mortality. Oropharyngeal dysphagia manifests as a multi-aetiological syndrome with diverse phenotypes. We advocate for a neurogeriatric perspective that integrates specific neurological insights with geriatric care principles to improve dysphagia management. This approach highlights the diagnostic value of disease-specific neurological dysphagia manifestations and recognises the condition as a potential target for neurological therapies, as shown by the benefits that acetylcholinesterase inhibitors in myasthenia gravis and dopaminergic agents in Parkinson's disease have against the syndrome. Age-related factors such as presbyphagia, which includes reduced pharyngeal sensation, sarcopenia, and decreased neuroplasticity, further contribute to the pathophysiology of oropharyngeal dysphagia. Cross-disease treatment strategies encompass oral hygiene, nutritional support, dietary modifications, individualised interventions to improve swallowing physiology, and emerging neurostimulation techniques that are currently under investigation. Current research aims to refine assessment protocols tailored to these interventions, identify outcome predictors to contextualise dysphagia findings, and evaluate the potential of neurostimulation or pharmacological agents, with the aim to improve quality of life and reduce mortality.
引用
- Labeit B, Lapa S, Lueg G, et al. Oropharyngeal dysphagia: a narrative review towards an integrated neurogeriatric perspective. Lancet Healthy Longev. 2025. PMID: 41349566. doi:10.1016/j.lanhl.2025.100794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。